Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF
December 3, 2001
- WORLD NEWS IN BRIEF
December 3, 2001
- Aiming at \2 Trillion Sales in FY2009: Kuraya Sanseido President
December 3, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
December 3, 2001
- Kissei Withdraws Additional Indication Application for Rizaben
December 3, 2001
- Nippon Roche, GSK/IPF Hold Seminars on Influenza
December 3, 2001
- Otsuka Signs Contract with Celera Genomics for Genomic Database
December 3, 2001
- OTC NEWS IN BRIEF
December 3, 2001
- Kyorin Beefs Up Globalization by Forming Subsidiary in Europe
December 3, 2001
- Semi-annual Sales of OTC Drugs Up 1.1% from Last Year: INTAGE Survey
December 3, 2001
- REGULATORY NEWS IN BRIEF
December 3, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -3-
November 26, 2001
- OTC NEWS IN BRIEF
November 26, 2001
- Daiichi Considers Independent Marketing in Europe: President Morita
November 26, 2001
- Top 10 Companies Report Bullish Interim Results
November 26, 2001
- MPC to Complete Marketing Line Integration by March
November 26, 2001
- Toru Nagashima Appointed New President at Teijin
November 26, 2001
- BUSINESS NEWS IN BRIEF
November 26, 2001
- Remicade, Simulect Designated as Orphans
November 26, 2001
- Pressure on Medical Fees Gains Momentum
November 26, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…